Self Testing Market Report including Significant Competitor Information, Identifying Major Players and Recent developments in the segment.

ReportsnReports added a new report on The Self Testing Market report delivers the clean elaborated structure of the Report comprising each and every business related information of the market at a global level. The complete range of information related to the Self Testing Market is obtained through various sources and this obtained bulk of the information is arranged, processed, and represented by a group of specialists through the application of different methodological techniques and analytical tools such as SWOT analysis to generate a whole set of trade based study regarding the Self Testing Market.

Download FREE PDF sample of this Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=2685446

Self Testing Market Top Companies and Product Overview:-
Atomo Diagnostics Pty Ltd Company Overview
bioLytical Laboratories Inc Company Overview
Boston Microfluidics Company Overview
Brigham and Women’s Hospital Company Overview
Emory University Company Overview
Entia Ltd Company Overview

and more…

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Self Testing pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

Scope of this Report-
– Extensive coverage of the Self Testing under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Self Testing and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry.

Single User License: US $ 2500

Get FLAT 20% Discount on this Report @ https://www.reportsnreports.com/purchase.aspx?name=2685446

Reasons to buy this Report-
The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve RandD strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
– Identify and understand important and diverse types of Self Testing under development.
– Develop market-entry and market expansion strategies.
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
– In-depth analysis of the product’s current stage of development, territory and estimated launch date.

Table of Contents in this Report-
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 Self Testing Overview 6
3 Products under Development 7
3.1 Self Testing – Pipeline Products by Stage of Development 7
3.2 Self Testing – Pipeline Products by Territory 8
3.3 Self Testing – Pipeline Products by Regulatory Path 9
3.4 Self Testing – Pipeline Products by Estimated Approval Date 10
3.5 Self Testing – Ongoing Clinical Trials 11
4 Self Testing – Pipeline Products under Development by Companies 12
4.1 Self Testing Companies – Pipeline Products by Stage of Development 12
4.2 Self Testing – Pipeline Products by Stage of Development 13
5 Self Testing Companies and Product Overview 14
5.1 Atomo Diagnostics Pty Ltd Company Overview 14
5.1.1 Atomo Diagnostics Pty Ltd Pipeline Products and Ongoing Clinical Trials Overview 14
5.2 bioLytical Laboratories Inc Company Overview 18
5.2.1 bioLytical Laboratories Inc Pipeline Products and Ongoing Clinical Trials Overview 18
5.3 Boston Microfluidics Company Overview 20
5.3.1 Boston Microfluidics Pipeline Products and Ongoing Clinical Trials Overview 20
5.4 Brigham and Women’s Hospital Company Overview 21
5.4.1 Brigham and Women’s Hospital Pipeline Products and Ongoing Clinical Trials Overview 21
5.5 Emory University Company Overview 22
5.5.1 Emory University Pipeline Products and Ongoing Clinical Trials Overview 22
5.6 Entia Ltd Company Overview 23
5.6.1 Entia Ltd Pipeline Products and Ongoing Clinical Trials Overview 23
5.7 InnaMed Inc Company Overview 24
5.7.1 InnaMed Inc Pipeline Products and Ongoing Clinical Trials Overview 24
5.8 Morgan Innovation And Technology Ltd Company Overview 26
5.8.1 Morgan Innovation And Technology Ltd Pipeline Products and Ongoing Clinical Trials Overview 26
5.9 Novosanis NV Company Overview 27
5.9.1 Novosanis NV Pipeline Products and Ongoing Clinical Trials Overview 27
5.10 OncoGenesis Company Overview 28
5.10.1 OncoGenesis Pipeline Products and Ongoing Clinical Trials Overview 28
5.11 Premier Medical Corporation Company Overview 29
5.11.1 Premier Medical Corporation Pipeline Products and Ongoing Clinical Trials Overview 29
5.12 Shanghai Kehua Bio-engineering Co Ltd Company Overview 30
5.12.1 Shanghai Kehua Bio-engineering Co Ltd Pipeline Products and Ongoing Clinical Trials Overview 30
5.13 Svenska Cellulosa Aktiebolaget Company Overview 31
5.13.1 Svenska Cellulosa Aktiebolaget Pipeline Products and Ongoing Clinical Trials Overview 31
5.14 Tasso, Inc. Company Overview 32
5.14.1 Tasso, Inc. Pipeline Products and Ongoing Clinical Trials Overview 32
5.15 Wellmetrix LLC Company Overview 33
5.15.1 Wellmetrix LLC Pipeline Products and Ongoing Clinical Trials Overview 33
6 Self Testing- Recent Developments 34
6.1 Sep 10, 2019: EKF Diagnostics Holdings: Half-year Report 34
6.2 Aug 19, 2019: Retirement of Dr. Sandra Horning and Appointment of Dr. Levi Garraway to Chief Medical Officer, Roche and Genentech 35
6.3 Aug 12, 2019: Biocept reports second quarter 2019 financial results 35
6.4 Jul 25, 2019: Roche reports very strong performance in the first half of 2019 – Outlook raised 37
6.5 Jul 15, 2019: EKF Diagnostics Holdings: Trading update 41
6.6 Jul 09, 2019: Mylan HIV Self Test receives WHO prequalification approval 42
6.7 Jun 14, 2019: Klobuchar, Murkowski introduce Legislation to Protect Consumers’ Private Health Data 42
6.8 Jun 11, 2019: Changes in Roche’s board of directors and corporate executive committee 44
6.9 Jun 11, 2019: Regulators demand more details on Roche’s $4.8bn Spark acquisition 45
6.10 May 08, 2019: Biocept reports first quarter 2019 financial results 45
6.11 Apr 25, 2019: Regarding the establishment of the new “EIKEN ROAD MAP 2019” management framework and the new medium-term management plan 47
6.12 Apr 25, 2019: Eiken Chemical announced its financial results for the fiscal year ended March 31, 2019 49
6.13 Apr 17, 2019: Roche reports a strong start in 2019 and raises the outlook for the full-year 49
6.14 Apr 04, 2019: First HIV self-test approved for sale in Australia now available from Atomo Diagnostics 52
6.15 Mar 28, 2019: Biocept reports 2018 fourth quarter and full year financial results 53
6.16 Mar 21, 2019: Roche sues U.S. executives in fight over diabetes test strips 57
6.17 Mar 13, 2019: EKF Diagnostics Holdings: Final results 57
6.18 Feb 27, 2019: Biocept and Providence Saint John’s Health Center collaborate to evaluate cerebrospinal fluid for use with liquid biopsy testing in metastatic cancer 62
6.19 Jan 31, 2019: Roche reports very strong results in 2018 63
6.20 Jan 24, 2019: Genentech announces Alexander Hardy as Chief Executive Officer 67
6.21 Jan 11, 2019: Shimadzu’s new preparative purification LC System provides high efficiency, saves space, and enables multi-sample processing 68
6.22 Jan 07, 2019: MES to launch the first YO Home Sperm Test for PCs with personalized YO SCORE 69
6.23 Jan 02, 2019: Roche Diabetes Care India appoints Dr. Gaurav Laroia as general manager 70
6.24 Dec 13, 2018: Devicare announces the positive results of the clinical trial with Lit-Control to prevent the encrustation of catheters in patients with lithiasis 70
6.25 Dec 11, 2018: Brigham researchers develop smartphone-based Ovulation Test 71
6.26 Dec 10, 2018: New member proposed for election to Roche Board of Directors 72
6.27 Dec 10, 2018: Roche names William Bill Anderson as CEO from January 01 2019 72
6.28 Dec 03, 2018: Roche to increase its payroll in Switzerland by 1.2 percent 73
6.29 Nov 30, 2018: European Patent granted for Colli-Pee 73
6.30 Nov 29, 2018: Australian TGA approves Atomo HIV Self Test as first rapid diagnostic test for home use 73
6.31 Nov 28, 2018: INSTI HIV Self Test earns WHO prequalification status for home testing 74
6.32 Nov 08, 2018: Colli-Pee approved by Mexican Health Authority 75
6.33 Oct 31, 2018: Biocept announces new executive hires to its sales and marketing organization 76
6.34 Oct 25, 2018: Exeltis Spain launches the world’s first ever digital urology solution 77
7 Appendix 78
7.1 Methodology 78

and more

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit 2020 Self Testing Market Report- Size, Growth, Analysis Of Key-players Types And Application, Outlook 2025